142 related articles for article (PubMed ID: 11368550)
1. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.
Castagnoli KP; Steyn SJ; Petzer JP; Van der Schyf CJ; Castagnoli N
Chem Res Toxicol; 2001 May; 14(5):523-7. PubMed ID: 11368550
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
Khalil AA; Davies B; Castagnoli N
Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
Pérez V; Morón J; Pastó M; Unzeta M
Neurobiology (Bp); 2000; 8(3-4):231-6. PubMed ID: 11225513
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration.
Castagnoli K; Petzer JB; Steyn SJ; van der Schyf CJ; Castagnoli N
Inflammopharmacology; 2003; 11(2):183-8. PubMed ID: 15035820
[TBL] [Abstract][Full Text] [Related]
5. A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties.
Chan HH; Tse MK; Kumar S; Zhuo L
Eur J Pharmacol; 2018 Jan; 818():254-262. PubMed ID: 29050969
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
7. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
Castagnoli K; Murugesan T
Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903
[TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
Shahi GS; Das NP; Moochhala SM
Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitory naphthoquinones from the roots of Lithospermum erythrorhizon.
Choi WH; Hong SS; Lee SA; Han XH; Lee KS; Lee MK; Hwang BY; Ro JS
Arch Pharm Res; 2005 Apr; 28(4):400-4. PubMed ID: 15918512
[TBL] [Abstract][Full Text] [Related]
10. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
11. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity.
Hauptmann N; Shih JC
Life Sci; 2001 Feb; 68(11):1231-41. PubMed ID: 11233991
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of MAO-B through chronic low-dose (R)-deprenyl treatment in C57BL/6 mice has no effect on basal neostriatal dopamine levels.
Steyn SJ; Castagnoli K; Steyn S; Castagnoli N
Exp Neurol; 2001 Apr; 168(2):434-6. PubMed ID: 11259132
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
Sagi Y; Weinstock M; Youdim MB
J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
[TBL] [Abstract][Full Text] [Related]
14. Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase.
Castagnoli K; Steyn SJ; Magnin G; Van Der Schyf CJ; Fourie I; Khalil A; Castagnoli N
Neurotox Res; 2002 Mar; 4(2):151-60. PubMed ID: 12829416
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
Mostert S; Petzer A; Petzer JP
Chem Biol Drug Des; 2016 May; 87(5):737-46. PubMed ID: 26684482
[TBL] [Abstract][Full Text] [Related]
16. [Tobacco--once a medicinal plant. Does it contain substances with medicinal properties?].
Budzianowski J
Przegl Lek; 2013; 70(10):865-8. PubMed ID: 24501813
[TBL] [Abstract][Full Text] [Related]
17. Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain.
Carr LA; Basham JK
Life Sci; 1991; 48(12):1173-7. PubMed ID: 2002748
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
19. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
20. Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice.
Takahata K; Shimazu S; Yoneda F; Ogawa M; Iida Y; Saji H
J Neural Transm (Vienna); 2003 Aug; 110(8):859-69. PubMed ID: 12898342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
